Literature DB >> 8933102

Human alcohol dehydrogenase isoenzyme activity in the sera of non-alcoholic liver cirrhotic patients.

L Chrostek1, M Szmitkowski.   

Abstract

The activities of class I and II alcohol dehydrogenase isoenzymes were examined in the sera of patients with non-alcoholic liver cirrhosis using a fluorometric method. The analysis of these results shows a statistically significant increase (2,5-times) in the activity of class I alcohol dehydrogenase, and no marked differences in the activity of class II in cirrhotic and control patients. The observed increase in total enzyme activity measured using a photometric method was not very high but confirmed the elevation of class I isoenzyme activity. Activities of both classes of alcohol dehydrogenase isoenzymes have a good correlation with aspartate aminotransferase. Class II isoenzyme activity additionally correlates with alkaline phosphatase. These results suggest that serum activity of class I alcohol dehydrogenase is a better indicator of liver cell destruction during non-alcoholic cirrhosis than total enzyme activity, and is comparable with the value of aspartate aminotransferase.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8933102     DOI: 10.1515/cclm.1996.34.10.801

Source DB:  PubMed          Journal:  Eur J Clin Chem Clin Biochem        ISSN: 0939-4974


  3 in total

1.  Activity of class I, II, III, and IV alcohol dehydrogenase isoenzymes in human gastric mucosa.

Authors:  Wojciech Jelski; Lech Chrostek; Maciej Szmitkowski; Wiktor Laszewicz
Journal:  Dig Dis Sci       Date:  2002-07       Impact factor: 3.199

2.  Alcohol dehydrogenase (ADH) isoenzymes and aldehyde dehydrogenase (ALDH) activity in the sera of patients with liver cancer.

Authors:  Wojciech Jelski; Bogdan Zalewski; Maciej Szmitkowski
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

3.  Activity of alcohol dehydrogenase isoenzymes and aldehyde dehydrogenase in sera of patients with hepatitis C.

Authors:  Wojciech Jelski; Anna Strumnik; Karolina Orywal; Tadeusz W Lapinski; Magdalena Swiderska; Maciej Szmitkowski
Journal:  Arch Med Sci       Date:  2016-06-07       Impact factor: 3.318

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.